Grace I. Dearden

Grace I. Dearden

Auto-generated profile, based on publicly available information

Grace I. Dearden

Department of Biochemistry and Biophysics, Weill Cornell Medicine, New York, New York 10065, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
EHEri Hirata
Eri Hirata
KSKen-Taro Sakata
Ken-Taro Sakata
GDGrace I. Dearden
Grace I. Dearden
FNFaria Noor
Faria Noor
IMIndu Menon
Indu Menon
AMAnant K. Menon
Anant K. Menon
The oligosaccharide needed for protein N -glycosylation is assembled on a lipid carrier via a multi-step pathway. Synthesis is initiated on the cytoplasmic face of the endoplasmic reticulum (ER) and completed on the luminal side after transbilayer translocation of a heptasaccharide lipid intermediate. More than 30 Congenital Disorders of Glycosylation (CDGs) are associated with this pathway, including RFT1-CDG which results from defects in the membrane protein Rft1. Rft1 is essential for the viability of yeast and mammalian cells and was proposed as the transporter needed to flip the heptasaccharide lipid intermediate across the ER membrane. However, other studies indicated that Rft1 is not required for heptasaccharide lipid flipping in microsomes or unilamellar vesicles reconstituted with ER membrane proteins, nor is it required for the viability of at least one eukaryote. It is therefore not known what essential role Rft1 plays in N -glycosylation. Here, we present a molecular characterization of human Rft1, using yeast cells as a reporter system. We show that it is a multi-spanning membrane protein located in the ER, with its N and C-termini facing the cytoplasm. It is not N -glycosylated. The majority of RFT1-CDG mutations map to highly conserved regions of the protein. We identify key residues that are important for Rft1’s ability to support N -glycosylation and cell viability. Our results provide a necessary platform for future work on this enigmatic protein.

23 April 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
SVSarina Veit
Sarina Veit
GDGrace I. Dearden
Grace I. Dearden
KMKartikeya M. Menon
Kartikeya M. Menon
FNFaria Noor
Faria Noor
IMIndu Menon
Indu Menon
TPThomas Günther Pomorski
Thomas Günther Pomorski
Scramblases play important roles in physiology by translocating phospholipids bidirectionally across cell membranes. For example, scrambling facilitated by dimers of the Voltage-Dependent Anion Channel 1 (VDAC1) enables endoplasmic reticulum-derived phospholipids to cross the outer membrane to enter mitochondria. Precise quantification of lipid scrambling, while critical for mechanistic understanding, cannot be obtained from ensemble averaged measurements of reconstituted scramblases. Here, we describe a microscopy platform for high-throughput imaging of single vesicles reconstituted with fluorescently labeled phospholipids and heterogeneously crosslinked VDAC1 dimers. For each vesicle, we quantify size, protein occupancy and scrambling rate. Notably, we find that individual VDAC1 dimers have different activities, ranging from 10,000 lipids per second. This kinetic heterogeneity, masked in ensemble measurements, reveals that only some dimer interfaces are capable of promoting rapid scrambling, as suggested by molecular dynamics simulations. We extend our analyses to opsin, a monomeric G protein-coupled receptor scramblase, thereby demonstrating the versatility of our platform for quantifying transbilayer lipid transport and exploring its regulation.